The Nogo-66 receptor: Focusing myelin inhibition of axon regeneration

Trends in Neurosciences

Volumn 26, Issue 4, 2003, Pages 193-198

  McGee, Aaron W ^a   Strittmatter, Stephen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; NOGO 66 RECEPTOR; PROTEIN; PROTEIN NOGO; PROTEIN P75; RECEPTOR; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; CONVALESCENCE; HUMAN; MOLECULAR MODEL; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEURITE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

EID: 0037384801     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00062-6     Document Type: Review

References (58)

1. Benfey M., Aguayo A.J. Extensive elongation of axons from rat brain into peripheral nerve grafts. Nature. 296:1982;150-152.
2. David S., Aguayo A.J. Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science. 214:1981;931-933.
3. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49:1999;377-391.
4. Schwab M.E., Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8:1988;2381-2393.
5. Schwab M.E., Thoenen H. Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J. Neurosci. 5:1985;2415-2423.
6. Bregman B.S., et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501.
7. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1:1988;85-96.
8. Cai D., et al. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 22:1999;89-101.
9. Schnell L., Schwab M.E. Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord. Eur. J. Neurosci. 5:1993;1156-1171.
10. Thallmair M., et al. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1:1998;124-131.
11. Prinjha R., et al. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
12. Chen M.S., et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
13. Grand-Pre T., et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
14. Huber A.B., et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22:2002;3553-3567.
15. Wang X., et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22:2002;5505-5515.
16. Josephson A., et al. Nogo mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp. Neurol. 169:2001;319-328.
17. Grand-Pre T., et al. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551.
18. Buffo A., et al. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured Purkinje cell axons. J. Neurosci. 20:2000;2275-2286.
19. Flanagan J.G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 63:1990;185-194.
20. Fournier A.E., et al. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346.
21. Josephson A., et al. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J. Comp. Neurol. 453:2002;292-304.
22. Fournier A.E., et al. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J. Neurosci. 22:2002;8876-8883.
23. Nieke J., Schachner M. Expression of the neural cell adhesion molecules L1 and N-CAM and their common carbohydrate epitope L2/HNK-1 during development and after transection of the mouse sciatic nerve. Differentiation. 30:1985;141-151.
24. Liu B.P., et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 297:2002;1190-1193.
25. Domeniconi M., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35:2002;283-290.
26. Wang K.C., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944.
27. Habib A.A., et al. Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J. Neurochem. 70:1998;1704-1711.
28. Mikol D.D., Stefansson K. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell Biol. 106:1988;1273-1279.
29. Mikol D.D., et al. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 110:1990;471-479.
30. McKerracher L., et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
31. Mukhopadhyay G., et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
32. Li C., et al. Myelination in the absence of myelin-associated glycoprotein. Nature. 369:1994;747-750.
33. Bartsch U., et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron. 15:1995;1375-1381.
34. Montag D., et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron. 13:1994;229-246.
35. Schafer M., et al. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron. 16:1996;1107-1113.
36. Yamashita T., et al. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157:2002;565-570.
37. Wang K.C., et al. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 420:2002;74-78.
38. NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5:2002;1302-1308.
39. NTR: novel functions and implications for diseases of the nervous system. Nat. Neurosci. 5:2002;1131-1136.
40. Roux P.P., Barker P.A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 67:2002;203-233.
41. Chan J.R., et al. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14661-14668.
42. NTR as a positive modulator of myelination. Science. 298:2002;1245-1248.
43. Nikolic M. The role of Rho GTPases and associated kinases in regulating neurite outgrowth. Int. J. Biochem. Cell Biol. 34:2002;731-745.
44. Fournier, A. et al. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23, 1416-1423.
45. Yamashita T., et al. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 24:1999;585-593.
46. Dergham P., et al. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22:2002;6570-6577.
47. Schoop V.M., et al. Critical period-dependent reduction of the permissiveness of cat visual cortex tissue for neuronal adhesion and neurite growth. Eur. J. Neurosci. 9:1997;1911-1922.
48. Pizzorusso T., et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science. 298:2002;1248-1251.
49. Bradbury E.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
50. Papadopoulos C.M., et al. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. 51:2002;433-441.
51. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature. 343:1990;269-272.
52. Merkler D., et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 21:2001;3665-3673.
53. Lehmann M., et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19:1999;7537-7547.
54. Jones L.L., et al. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J. Physiol. 533:2001;83-89.
55. Neumann S., et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 34:2002;885-893.
56. Qiu J., et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 34:2002;895-903.
57. Buchanan S.G., Gay N.J. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65:1996;1-44.
58. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11:2001;725-732.